Quantum Biopharma (QNTM) Total Liabilities (2018 - 2026)

Quantum Biopharma's Total Liabilities history runs 9 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 58.02% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (up 58.02% YoY), while the FY2025 annual figure was $6.1 million, down 9.29% from the prior year.
• Total Liabilities came in at $16.3 million for Q1 2026 at Quantum Biopharma, up from $6.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $16.3 million in Q1 2026 to a low of $3.7 million in Q3 2024.
• A 5-year average of $7.7 million and a median of $6.6 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities sank 41.98% in 2023 and soared 163.62% in 2025, its largest moves.
• Quantum Biopharma's Total Liabilities stood at $7.9 million in 2022, then plunged by 41.98% to $4.6 million in 2023, then jumped by 46.29% to $6.7 million in 2024, then slipped by 9.29% to $6.1 million in 2025, then jumped by 169.81% to $16.3 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $16.3 million, $6.1 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison